Van Training and Research Hospital, University of Health Sciences, Van, Turkey.
Istanbul Faculty of Medicine, EMAR Medical Center, Istanbul University, Istanbul, Turkey.
J Headache Pain. 2023 Mar 13;24(1):24. doi: 10.1186/s10194-023-01555-8.
Headaches are frequent neurological disorders that are yet to be unveiled and treated comprehensively worldwide. Bearing in mind that the distribution of headache subtypes in neurology clinics (NC) is essential for planning appropriate diagnostic and therapeutic approaches, the primary goals of this multi-centric study are to carry out inter-regional comparisons by using current diagnostic criteria with evaluations of neurologists to delineate headache burden.
A cross-sectional study between April 1 and May 16, 2022 was conducted with the participation of 13 countries from the Middle East, Asia, and Africa. Patients were included in the study on a specific day each week during five consecutive weeks. All volunteers over the age of 18 and whose primary cause for admission was headache were examined. The patients admitted to NC or referred from emergency services/other services were evaluated by neurologists by means of the International Classification of Headache Disorders (ICHD-3) criteria.
Among the 13,794 patients encountered in NC, headache was the primary complaint in 30.04%. The headache patients' mean age was 42.85 ± 14.89 (18-95 years), and 74.3% were female. According to the ICHD-3 criteria, 86.7% of the main group had primary headache disorders, 33.5% had secondary headaches, 4% had painful cranial neuropathies along with other facial and headaches, and 5.2% had headaches included in the appendix part showing some overlapping conditions. While the most common primary headache was migraine without aura (36.8%), the most common secondary headache was medication-overuse headache (MOH) (9.8%). Headaches attributed to COVID-19, its secondary complications, or vaccines continue to occur at rates of 1.2%-3.5% in current neurology practice. Pain severity was significantly lower in Ivory Coast and Sudan than in Türkiye, Turkish Republic of Northern Cyprus, Iran, Egypt, Senegal, Tatarstan, and Azerbaijan (p < 0.001).
The study showed that migraine is still the most common motive for admissions to NC in different regions. Furthermore, MOH, an avoidable disorder, is the most common secondary headache type and appears to be a significant problem in all regions. Remarkably, pain perception differs between regions, and pain intensity is lower in Africa than in other regions.
头痛是一种常见的神经系统疾病,尚未在全球范围内得到充分揭示和治疗。鉴于神经科诊所(NC)中头痛亚型的分布对于规划适当的诊断和治疗方法至关重要,这项多中心研究的主要目标是通过使用当前的诊断标准和神经科医生的评估进行区域间比较,以描绘头痛负担。
2022 年 4 月 1 日至 5 月 16 日进行了一项横断面研究,有来自中东、亚洲和非洲的 13 个国家参与。在连续五周的每周特定一天,将患者纳入研究。所有年龄在 18 岁以上、主要因头痛入院的志愿者均接受检查。由神经科医生根据国际头痛疾病分类(ICHD-3)标准对 NC 入院或从急诊/其他服务转来的患者进行评估。
在 NC 中遇到的 13794 名患者中,30.04%的患者以头痛为主要主诉。头痛患者的平均年龄为 42.85±14.89(18-95 岁),74.3%为女性。根据 ICHD-3 标准,主要组中有 86.7%的患者患有原发性头痛障碍,33.5%的患者患有继发性头痛,4%的患者患有伴有其他面部和头痛的疼痛性颅神经病,5.2%的患者患有头痛附录部分显示出一些重叠情况。虽然最常见的原发性头痛是无先兆偏头痛(36.8%),但最常见的继发性头痛是药物过度使用性头痛(MOH)(9.8%)。在当前神经科实践中,归因于 COVID-19、其继发性并发症或疫苗的头痛继续以 1.2%-3.5%的比例发生。科特迪瓦和苏丹的疼痛严重程度明显低于土耳其、北塞浦路斯土耳其共和国、伊朗、埃及、塞内加尔、鞑靼斯坦和阿塞拜疆(p<0.001)。
该研究表明,偏头痛仍然是不同地区 NC 入院的最常见原因。此外,MOH 是一种可避免的疾病,是最常见的继发性头痛类型,并且在所有地区似乎都是一个重大问题。值得注意的是,不同地区的疼痛感知存在差异,非洲的疼痛强度低于其他地区。